Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
Daniel T Grima1, Stephen T Brown1, Laveena Kamboj2, Kevin R Bainey3, Ron Goeree4,5, Paul Oh6, Krishnan Ramanathan7, Shaun G Goodman81Cornerstone Research Group, Burlington, ON, 2AstraZeneca Canada, Mississauga, ON, 3Mazankowski Alberta Heart Institute/University of Alberta Hospital, Edmonton, AB, 4P...
Main Authors: | Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-01-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/cost-effectiveness-of-ticagrelor-versus-clopidogrel-in-patients-with-a-a15617 |
Similar Items
-
Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
by: Amir Hashemi-meshkini, et al.
Published: (2023-04-01) -
Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
by: David Gasche, et al.
Published: (2013-09-01) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01) -
Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis
by: He Meijiao, et al.
Published: (2022-02-01) -
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
by: Nikita Lomakin, et al.
Published: (2019-12-01)